Advanced skin cancer guidance
Final draft guidance recommends nivolumab for advanced skin cancer
The National Institute for Health and Care Excellence (NICE) England, on Friday 22 January said yes to nivolumab as monotherapy for treating advanced skin cancer in final draft guidance. ….more